Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Vitamin A affects hair loss and immune response in alopecia areata.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

New research is helping develop better treatments for alopecia areata.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

New therapies are being developed that target integrin pathways to treat various diseases.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.